First stem-cell fraud case enters courts

| | July 16, 2012
b e fda b bdd b edccd
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Stem cell tourism may be on its last legs. Six Los Angeles residents are suing South Korean company RNL Bio and its associates in California for alleged fraud. They claim the company persuaded them to travel to clinics in South Korea, Mexico or China to donate fat tissue and have stem cells from it readministered to cure diseases and even counteract ageing.

View the original article here: First stem-cell fraud case enters courts

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend